Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Paleolog

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Vascular Research|November 25, 2010
Venous hypoxia: a poorly studied etiological factor of varicose veinsC S Lim, M S Gohel, A C Shepherd, et al.
Gene Therapy|April 9, 2002
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1J W B Bainbridge, A Mistry, M De Alwis, et al.
Annals of the Rheumatic Diseases|October 29, 2000
Future prospects for anti-cytokine treatmentM Feldmann, J Miotla, E Paleolog, et al.
Cytokine|March 1, 1993
The effects of tumor necrosis factor (TNF) derivatives on TNF receptorsH Tchorzewski, K Zeman, E Paleolog, et al.
Arthritis and Rheumatism|January 22, 2000
Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritisP C Taylor, A M Peters, E Paleolog, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|July 1, 1996
Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell modelM F Ledda, S Adris, A I Bravo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolutionB Modarai, J Humphries, K G Burnand, et al.
Mediators of Inflammation|January 1, 1993
The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitroH Tchorzewski, K Zeman, J Kantorski, et al.
Cytokine|July 1, 1993
Antilipid a monoclonal antibody HA-1A: immune complex clearance of endotoxin reduces TNF-alpha, IL-1 beta and IL-6 productionP Katsikis, G Harris, T Page, et al.
Immunological Reviews|April 1, 1995
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid diseaseR N Maini, M J Elliott, F M Brennan, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Vascular Research|November 25, 2010
Venous hypoxia: a poorly studied etiological factor of varicose veinsC S Lim, M S Gohel, A C Shepherd, et al.
Gene Therapy|April 9, 2002
Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1J W B Bainbridge, A Mistry, M De Alwis, et al.
Annals of the Rheumatic Diseases|October 29, 2000
Future prospects for anti-cytokine treatmentM Feldmann, J Miotla, E Paleolog, et al.
Cytokine|March 1, 1993
The effects of tumor necrosis factor (TNF) derivatives on TNF receptorsH Tchorzewski, K Zeman, E Paleolog, et al.
Arthritis and Rheumatism|January 22, 2000
Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritisP C Taylor, A M Peters, E Paleolog, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|July 1, 1996
Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell modelM F Ledda, S Adris, A I Bravo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 2, 2008
Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolutionB Modarai, J Humphries, K G Burnand, et al.
Mediators of Inflammation|January 1, 1993
The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitroH Tchorzewski, K Zeman, J Kantorski, et al.
Cytokine|July 1, 1993
Antilipid a monoclonal antibody HA-1A: immune complex clearance of endotoxin reduces TNF-alpha, IL-1 beta and IL-6 productionP Katsikis, G Harris, T Page, et al.
Immunological Reviews|April 1, 1995
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid diseaseR N Maini, M J Elliott, F M Brennan, et al.
Pageof 3